Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium MW Radomski, RMJ Palmer, S Moncada The Lancet 330 (8567), 1057-1058, 1987 | 1970 | 1987 |
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. MW Radomski, RM Palmer, S Moncada Proceedings of the National Academy of Sciences 87 (13), 5193-5197, 1990 | 1713 | 1990 |
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. MW Radomski, RM Palmer, S Moncada British journal of pharmacology 92 (3), 639, 1987 | 1562 | 1987 |
Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. MW Radomski, RM Palmer, S Moncada Proceedings of the National Academy of Sciences 87 (24), 10043-10047, 1990 | 1428 | 1990 |
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. MW Radomski, RM Palmer, S Moncada British journal of pharmacology 92 (1), 181, 1987 | 1125 | 1987 |
Nanoparticles: pharmacological and toxicological significance C Medina, MJ Santos‐Martinez, A Radomski, OI Corrigan, MW Radomski British journal of pharmacology 150 (5), 552-558, 2007 | 1041 | 2007 |
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium MW Radomski, RMJ Palmer, S Moncada Biochemical and biophysical research communications 148 (3), 1482-1489, 1987 | 991 | 1987 |
Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function S Moncada, MW Radomski, RMJ Palmer Biochemical pharmacology 37 (13), 2495-2501, 1988 | 873 | 1988 |
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency A Lesniak, A Salvati, MJ Santos-Martinez, MW Radomski, KA Dawson, ... Journal of the American Chemical Society 135 (4), 1438-1444, 2013 | 861 | 2013 |
Nanoparticle‐induced platelet aggregation and vascular thrombosis A Radomski, P Jurasz, D Alonso‐Escolano, M Drews, M Morandi, ... British journal of pharmacology 146 (6), 882-893, 2005 | 836 | 2005 |
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart PY Cheung, G Sawicki, M Wozniak, W Wang, MW Radomski, R Schulz Circulation 101 (15), 1833-1839, 2000 | 620 | 2000 |
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages M Di Rosa, M Radomski, R Carnuccio, S Moncada Biochemical and biophysical research communications 172 (3), 1246-1252, 1990 | 569 | 1990 |
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. MA Moro, RJ Russel, S Cellek, I Lizasoain, Y Su, VM Darley-Usmar, ... Proceedings of the National Academy of Sciences 93 (4), 1480-1485, 1996 | 565 | 1996 |
Magnetic nanoparticles in cancer theranostics OL Gobbo, K Sjaastad, MW Radomski, Y Volkov, A Prina-Mello Theranostics 5 (11), 1249, 2015 | 505 | 2015 |
Paradoxical fate and biological action of peroxynitrite on human platelets. MA Moro, VM Darley-Usmar, DA Goodwin, NG Read, R Zamora-Pino, ... Proceedings of the National Academy of Sciences 91 (14), 6702-6706, 1994 | 463 | 1994 |
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation P Jurasz, D Alonso-Escolano, MW Radomski British journal of pharmacology 143 (7), 819, 2004 | 447 | 2004 |
Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor C Fernandez-Patron, MW Radomski, ST Davidge Circulation research 85 (10), 906-911, 1999 | 440 | 1999 |
Nitric oxide synthase activities in human myocardium AJ de Belder, HJF Why, PJ Richardson, CA Bucknall, JF Martin, ... The Lancet 341 (8837), 84-85, 1993 | 434 | 1993 |
Release of gelatinase A during platelet activation mediates aggregation G Sawicki, E Salas, J Murat, H Miszta-Lane, MW Radomski Nature 386 (6625), 616-619, 1997 | 429 | 1997 |
Characterization of the l‐arginine: nitric oxide pathway in human platelets MW Radomski, RMJ Palmer, S Moncada British journal of pharmacology 101 (2), 325-328, 1990 | 428 | 1990 |